Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

Anavex Awarded New U.S. Patent

GlobeNewswire June 4, 2014

Anavex Appoints Dr. Abraham Fisher to Scientific Advisory Board

GlobeNewswire May 28, 2014

Anavex Reports That New Data Confirms Calcium Target Over-Expression May be Involved in Causing Alzheimer's Disease

GlobeNewswire May 22, 2014

Anavex Provides Business Update Including Clinical Trial Plans for ANAVEX PLUS in Alzheimer's Disease

GlobeNewswire May 15, 2014

Anavex Strengthens Scientific Advisory Board With Clinical Trial Expert

GlobeNewswire May 12, 2014

Anavex Appoints Senior Healthcare and Pharmaceutical Executives to Board of Directors

GlobeNewswire May 8, 2014

Anavex Encouraged by Scientific Data Confirming Sigma-1 Receptor Agonist is Potentially Disease-Modifying in Parkinson's Disease

GlobeNewswire April 29, 2014

Anavex Strengthens Alzheimer's Pipeline, Obtains Exclusive Worldwide Rights to Intellectual Property

GlobeNewswire March 31, 2014

Anavex Reports Predicted Clinical Effect of Both ANAVEX 2-73 and ANAVEX PLUS in a Humanized Cortical Cognitive Model for Alzheimer's Disease

GlobeNewswire March 27, 2014

Anavex Successfully Closes $10 Million Financing to Initiate Phase 1b/2a Alzheimer's Clinical Trial

GlobeNewswire March 19, 2014

Anavex Announces $10 Million Private Placement of Convertible Debentures

GlobeNewswire March 13, 2014

Anavex Encouraged By Scientific Data Confirming Sigma-1 Receptor Agonist Extends Survival in ALS (Lou Gehrig's Disease)

GlobeNewswire March 10, 2014

Anavex: Research Report Reveals Cardioprotective Action of Sigma-1 Receptor Agonists

GlobeNewswire March 4, 2014

Research Report Confirms Opportunity for Anavex Anti-Cancer and Neuropathic Pain Compounds

GlobeNewswire February 26, 2014

Anavex to Present at 16th Annual BIO CEO & Investor Conference

Globe Newswire February 3, 2014

Sigma-1 receptor Implicated in Cell Survival of Rare Neurodegenerative Diseases - Expanding the Opportunity for Application of ANAVEX PLUS in Rare Diseases

Globe Newswire January 23, 2014

Anavex Agreement With The Roskamp Institute to Advance the Clinical Development of ANAVEX PLUS

Globe Newswire January 13, 2014

Anavex CEO Invited to Present at Upcoming Investment Conferences

Globe Newswire January 7, 2014

Anavex Appoints Clinical Design Expert to Scientific Advisory Board

Globe Newswire December 10, 2013

Anavex Appoints Alzheimer's Industry Leader to Scientific Advisory Board

PR Newswire December 3, 2013